| 000 | 01559 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517094941.0 | ||
| 264 | 0 | _c20180104 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1468-1331 | ||
| 024 | 7 |
_a10.1111/ene.13054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLegris, N | |
| 245 | 0 | 0 |
_aTelemedicine for the acute management of stroke in Burgundy, France: an evaluation of effectiveness and safety. _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _c09 2016 |
||
| 300 |
_a1433-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBrain Ischemia _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 |
_aStroke _xcomplications |
| 650 | 0 | 4 |
_aTelemedicine _xmethods |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xmethods |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHervieu-Bègue, M | |
| 700 | 1 | _aDaubail, B | |
| 700 | 1 | _aDaumas, A | |
| 700 | 1 | _aDelpont, B | |
| 700 | 1 | _aOsseby, G-V | |
| 700 | 1 | _aRouaud, O | |
| 700 | 1 | _aGiroud, M | |
| 700 | 1 | _aBéjot, Y | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 23 _gno. 9 _gp. 1433-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ene.13054 _zAvailable from publisher's website |
| 999 |
_c26034101 _d26034101 |
||